Abstract
Cefmetazole (CMZ) was intravenously injected to 12 patients with acute prostatitis as well as 3 patients with acute epididymitis.
Good clinical results were obtained in 10 patients (91.7%) with acute prostatitis and 2 patients (100%) with acute epididymitis.
No side effects were reported in all of 23 patients. Thus, CMZ could be expected to reveal good response in the treatment of male genital infections.